Aridis Pharmaceuticals Inc (ARDS)
0.0608
0.00 (0.00%)
USD |
OTCM |
May 22, 15:26
Aridis Pharmaceuticals Total Liabilities (Quarterly): 18.34M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 18.34M |
| June 30, 2023 | 21.40M |
| March 31, 2023 | 37.32M |
| December 31, 2022 | 38.93M |
| September 30, 2022 | 47.94M |
| June 30, 2022 | 44.62M |
| March 31, 2022 | 44.23M |
| December 31, 2021 | 39.91M |
| September 30, 2021 | 30.24M |
| June 30, 2021 | 24.87M |
| March 31, 2021 | 26.12M |
| December 31, 2020 | 23.80M |
| Date | Value |
|---|---|
| September 30, 2020 | 23.40M |
| June 30, 2020 | 24.19M |
| March 31, 2020 | 24.38M |
| December 31, 2019 | 24.33M |
| September 30, 2019 | 25.59M |
| June 30, 2019 | 5.012M |
| March 31, 2019 | 4.541M |
| December 31, 2018 | 5.297M |
| September 30, 2018 | 7.203M |
| June 30, 2018 | 13.91M |
| March 31, 2018 | 18.80M |
| December 31, 2017 | 15.04M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.012M
Minimum
Jun 2019
47.94M
Maximum
Sep 2022
29.15M
Average
25.23M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 25.29M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 0.9087M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.534M |
| Shareholders Equity (Quarterly) | -11.80M |